Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Camrelizumab Plus Carboplatin and Paclitaxel as First-Lin... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
0
Authors
Shengxiang Ren
32 more
Shengxiang Ren
•
Jianhua Chen
30 more
•
Caicun Zhou
Published
December 16, 2021
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Journal of Thoracic Oncology
Topics
Medicine
Cancer Oncology
Internal Medicine
Surgery
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1016/j.jtho.2021.11.018
License
publisher-specific-oa
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Journal of Thoracic Oncology
Topics
Medicine
Cancer Oncology
Internal Medicine
Surgery
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1016/j.jtho.2021.11.018
License
publisher-specific-oa
